Table 2. The correlations of the serum miR-375-3p level with SCLC clinical features in cohort 3.
Clinical features | Group | Low miR-375-3p expression | High miR-375-3p expression | P value |
---|---|---|---|---|
Sex | Female | 6 | 8 | 0.5906 |
Male | 28 | 27 | ||
Age | <60 | 14 | 14 | 0.9207 |
≥60 | 20 | 21 | ||
T | T1-T2 | 19 | 9 | 0.0107* |
T3-T4 | 15 | 26 | ||
N | N0-N1 | 9 | 1 | 0.0053** |
N2-N3 | 25 | 34 | ||
M | M0 | 23 | 17 | 0.1085 |
M1 | 11 | 18 | ||
Stage | I-II | 5 | 0 | 0.0185* |
III-IV | 29 | 35 |
SCLC, small cell lung cancer; T, tumor; N, node; M, metastasis. *, P<0.05; **, P<0.01.